After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Pfizer Inc. is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – General industry. At the end of the last regular session, the stock closed at $26.79 and fluctuated between $27.32 as its day high and $26.76 as its day low. The current market capitalization of Pfizer Inc. is $151.28B. A total of 43.6 million shares were traded on the day, compared to an average of 48.87M shares.
In the most recent transaction, Gottlieb Scott bought 3,000 shares of PFE for 26.47 per share on Dec 15 ’23. After the transaction, the Director now owns 9,000 company shares. In a previous transaction on May 08 ’23, Gottlieb Scott bought 1,000 shares at 38.58 per share. PFE shares that Director owns now total 6,000.
Among the insiders who bought shares, Gottlieb Scott acquired of 1,000 shares on May 05 ’23 at a per-share price of $38.42. This resulted in the Director holding 5,000 shares of PFE after the transaction. In another insider transaction, PFIZER INC bought 1,811,594 shares at $2.76 per share on Mar 17 ’23. Company shares held by the 10% Owner now total 5,952,263.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Pfizer Inc. pays an annual dividend of $1.65, resulting in a dividend yield of 6.16%, and it has a price to earnings (P/E) ratio of 74.54. PFE’s most recent ex-dividend date was 1/25/2024 when it declared a $0.42 quarterly dividend that was paid in cash on 3/1/2024. Previously, the company paid the dividend on 12/4/2023 with an ex-dividend date of 11/9/2023. The PFE stock dividend was $0.41 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, PFE has a high of $42.22 and a low of $25.61.
As of this writing, PFE has an earnings estimate of $0.54 per share for the current quarter. EPS was calculated based on a consensus of 14 estimates, with a high estimate of $0.82 per share and a lower estimate of $0.4. The company reported an EPS of -$0.17 in the last quarter, which was 50.00% higher than expectations of -$0.34.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. PFE’s latest balance sheet shows that the firm has $31.07B in Cash & Short Term Investments as of fiscal 2021. There were $37.00B in debt and $42.67B in liabilities at the time. Its Book Value Per Share was $15.77, while its Total Shareholder’s Equity was $77.46B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PFE is Buy with a score of 3.89.
